Newborn screening for primary immunodeficiency diseases: The past, the present and the future

International Journal of Neonatal Screening

Volumn 3, Issue 3, 2017, Pages

  King, Jovanka ^a,b   Ludvigsson, Jonas F ^c,d   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Örebro University   (Sweden)

Author keywords

KREC; Newborn screening; Next generation sequencing; Primary immunodeficiency diseases; TREC

Indexed keywords

EID: 85039036458     PISSN: None     EISSN: 2409515X     Source Type: Journal    
DOI: 10.3390/ijns3030019     Document Type: Review

References (37)

1. Itan, Y.; Shang, L.; Boisson, B.; Patin, E.; Bolze, A.; Moncada-Velez, M.; Scott, E.; Ciancanelli, M.J.; Lafaille, F.G.; Markle, J.G.; et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. USA 2015, 112, 13615-13620. [CrossRef] [PubMed]
2. Pai, S.Y.; Logan, B.R.; Griffith, L.M.; Buckley, R.H.; Parrott, R.E.; Dvorak, C.C.; Kapoor, N.; Hanson, I.C.; Filipovich, A.H.; Jyonouchi, S.; et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N. Engl. J. Med. 2014, 371, 434-446. [CrossRef] [PubMed]
3. Guthrie, R.; Susi, A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963, 32, 338-343. [PubMed]
4. Wilson, J.; Jungner, G. The principles and Practice of Screening for Disease; World Health Organization: Geneva, Switzerland, 1968.
5. Kwan, A.; Abraham, R.S.; Currier, R.; Brower, A.; Andruszewski, K.; Abbott, J.K.; Baker, M.; Ballow, M.; Bartoshesky, L.E.; Bonilla, F.A.; et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014, 312, 729-738. [CrossRef] [PubMed]
6. Barbaro, M.; Ohlsson, A.; Borte, S.; Jonsson, S.; Zetterström, R.H.; King, J.; Winiarski, J.; von Döbeln, U.; Hammarström, L. Newborn screening for severe primary immunodeficiency diseases in sweden-a 2-year pilot trec and krec screening study. J. Clin. Immunol. 2017, 37, 51-60. [CrossRef] [PubMed]
7. Chan, K.; Puck, J.M. Development of population-based newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2005, 115, 391-398. [CrossRef] [PubMed]
8. Dorsey, M.; Puck, J. Newborn screening for severe combined immunodeficiency in the US: Current status and approach to management. Int. J. Neonatal Screen. 2017, 3, 15. [CrossRef]
9. Chien, Y.-H.; Yu, H.-H.; Lee, N.-C.; Ho, H.-C.; Kao, S.-M.; Lu, M.-Y.; Jaing, T.-H.; Lee, W.-I.; Chang, K.-W.; Shieh, C.-C.; et al. Newborn screening for severe combined immunodeficiency in Taiwan. Int. J. Neonatal Screen. 2017, 3, 16. [CrossRef]
10. Rechavi, E.; Lev, A.; Saraf-Levy, T.; Etzioni, A.; Almashanu, S.; Somech, R. Newborn screening for severe combined immunodeficiency in Israel. Int. J. Neonatal Screen. 2017, 3, 13. [CrossRef]
11. Blom, M.; Pico-Knijnenburg, I.; Sijne-van Veen, M.; Boelen, A.; Bredius, R.G.M.; van der Burg, M.; Schielen, P.C.J.I. An evaluation of the trec assay with regard to the integration of scid screening into the Dutch newborn screening program. Clin. Immunol. 2017, 180, 106-110. [CrossRef] [PubMed]
12. Audrain, M.; Thomas, C.; Mirallie, S.; Bourgeois, N.; Sebille, V.; Rabetrano, H.; Durand-Zaleski, I.; Boisson, R.; Persyn, M.; Pierres, C.; et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on guthrie cards in a french single centre study. Clin. Immunol. 2014, 150, 137-139. [CrossRef] [PubMed]
13. De Felipe, B.; Olbrich, P.; Lucenas, J.M.; Delgado-Pecellin, C.; Pavon-Delgado, A.; Marquez, J.; Salamanca, C.; Soler-Palacin, P.; Gonzalez-Granado, L.I.; Antolin, L.F.; et al. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville. Pediatr. Allergy Immunol. 2016, 27, 70-77. [CrossRef] [PubMed]
14. Kanegae, M.P.; Barreiros, L.A.; Mazzucchelli, J.T.; Hadachi, S.M.; de Figueiredo Ferreira Guilhoto, L.M.; Acquesta, A.L.; Genov, I.R.; Holanda, S.M.; Di Gesu, R.S.; Goulart, A.L.; et al. Neonatal screening for severe combined immunodeficiency in Brazil. J. Pediatr. (Rio J) 2016, 92, 374-380. [CrossRef] [PubMed]
15. Nakagawa, N.; Imai, K.; Kanegane, H.; Sato, H.; Yamada, M.; Kondoh, K.; Okada, S.; Kobayashi, M.; Agematsu, K.; Takada, H.; et al. Quantification of kappa-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J. Allergy Clin. Immunol. 2011, 128, 223-225. [CrossRef] [PubMed]
16. Borte, S.; von Döbeln, U.; Fasth, A.; Wang, N.; Janzi, M.; Winiarski, J.; Sack, U.; Pan-Hammarström, Q.; Borte, M.; Hammarström, L. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012, 119, 2552-2555. [CrossRef] [PubMed]
17. Bruton, O.C. Agammaglobulinemia. Pediatrics 1952, 9, 722-728. [PubMed]
18. Bruton, O.C. Agammaglobulinemia (congenital absence of gamma globulin); report of a case. Med. Ann. Dist. Columbia 1953, 22, 648-650. [PubMed]
19. Vetrie, D.; Vorechovsky, I.; Sideras, P.; Holland, J.; Davies, A.; Flinter, F.; Hammarstrom, L.; Kinnon, C.; Levinsky, R.; Bobrow, M.; et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993, 361, 226-233. [CrossRef] [PubMed]
20. Picard, C.; Al-Herz, W.; Bousfiha, A.; Casanova, J.L.; Chatila, T.; Conley, M.E.; Cunningham-Rundles, C.; Etzioni, A.; Holland, S.M.; Klein, C.; et al. Primary immunodeficiency diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 2015, 35, 696-726. [CrossRef] [PubMed]
21. Grazioli, S.; Bennett, M.; Hildebrand, K.J.; Vallance, H.; Turvey, S.E.; Junker, A.K. Limitation of TREC-based newborn screening for ZAP70 severe combined immunodeficiency. Clin. Immunol. 2014, 153, 209-210. [CrossRef] [PubMed]
22. Hauck, F.; Blumenthal, B.; Fuchs, S.; Lenoir, C.; Martin, E.; Speckmann, C.; Vraetz, T.; Mannhardt-Laakmann, W.; Lambert, N.; Gil, M.; et al. Syk expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling. Clin. Immunol. 2015, 161, 103-109. [CrossRef] [PubMed]
23. Kuo, C.Y.; Chase, J.; Garcia Lloret, M.; Stiehm, E.R.; Moore, T.; Aguilera, M.J.; Lopez Siles, J.; Church, J.A. Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome. J. Allergy Clin. Immunol. 2013, 131, 1693-1695. [CrossRef] [PubMed]
24. Lev, A.; Simon, A.J.; Broides, A.; Levi, J.; Garty, B.Z.; Rosenthal, E.; Amariglio, N.; Rechavi, G.; Somech, R. Thymic function in mhc class II-deficient patients. J. Allergy Clin. Immunol. 2013, 131, 831-839. [CrossRef] [PubMed]
25. Lyttle, A.; Roifman, C.; Dadi, H.; Wright, N.; Kavadas, F. MHC class II deficiency in the Dene native population: A case report highlighting pitfalls in diagnosis and treatment. Allergy Asthma Clin. Immunol. 2014, 10, A1. [CrossRef]
26. Speckmann, C.; Neumann, C.; Borte, S.; la Marca, G.; Sass, J.O.; Wiech, E.; Fisch, P.; Schwarz, K.; Buchholz, B.; Schlesier, M.; et al. Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis. J. Allergy Clin. Immunol. 2012, 130, 991-994. [CrossRef] [PubMed]
27. Janzi, M.; Sjöberg, R.; Wan, J.; Fischler, B.; von Döbeln, U.; Isaac, L.; Nilsson, P.; Hammarström, L. Screening for C3 deficiency in newborns using microarrays. PLoS ONE 2009, 4, e5321. [CrossRef] [PubMed]
28. Hamsten, C.; Skattum, L.; Truedsson, L.; von Döbeln, U.; Uhlén, M.; Schwenk, J.M.; Hammarström, L.; Nilsson, P.; Neiman, M. Heat differentiated complement factor profiling. J. Proteom. 2015, 126, 155-162. [CrossRef] [PubMed]
29. Rosenfeld, M.; Sontag, M.K.; Ren, C.L. Cystic fibrosis diagnosis and newborn screening. Pediatr. Clin. N. Am. 2016, 63, 599-615. [CrossRef] [PubMed]
30. Borte, S.; Meeths, M.; Liebscher, I.; Krist, K.; Nordenskjold, M.; Hammarstrom, L.; von Dobeln, U.; Henter, J.I.; Bryceson, Y.T. Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies. J. Allergy Clin. Immunol. 2014, 134, 226-228. [CrossRef] [PubMed]
31. Stranneheim, H.; Wedell, A. Exome and genome sequencing: A revolution for the discovery and diagnosis of monogenic disorders. J. Intern. Med. 2016, 279, 3-15. [CrossRef] [PubMed]
32. Pavey, A.R.; Bodian, D.L.; Vilboux, T.; Khromykh, A.; Hauser, N.S.; Huddleston, K.; Klein, E.; Black, A.; Kane, M.S.; Iyer, R.K.; et al. Utilization of genomic sequencing for population screening of immunodeficiencies in the newborn. Genet. Med. 2017. [CrossRef] [PubMed]
33. Boyle, J.M.; Buckley, R.H. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 2007, 27, 497-502. [CrossRef] [PubMed]
34. Berg, J.S.; Agrawal, P.B.; Bailey, D.B.; Beggs, A.H.; Brenner, S.E.; Brower, A.M.; Cakici, J.A.; Ceyhan-Birsoy, O.; Chan, K.; Chen, F.; et al. Newborn sequencing in genomic medicine and public health. Pediatrics 2017, 139, e20162252. [CrossRef] [PubMed]
35. Friedman, J.M.; Cornel, M.C.; Goldenberg, A.J.; Lister, K.J.; Sénécal, K.; Vears, D.F.; The Global Alliance for Genomics and Health Regulatory and Ethics Working Group Paediatric Task Team. Genomic newborn screening: Public health policy considerations and recommendations. BMC Med. Genom. 2017, 10, 9. [CrossRef] [PubMed]
36. Tambe, P.; Sammons, H.M.; Choonara, I. Child mortality of children aged 5-15 years in the UK and Sweden: A comparison. Arch. Dis. Child. 2016, 101, 409-410. [CrossRef] [PubMed]
37. Tambe, P.; Sammons, H.M.; Choonara, I. Why do young children die in the UK? A comparison with sweden. Arch. Dis. Child. 2015, 100, 928-931. [CrossRef] [PubMed]